Trade Names: | |
Synonyms: | |
Status: | Approved (2000) |
Entry Type: | Protein |
Molecule Category: | Parent |
ATC: | A10AE04 |
UNII: | 2ZM8CX04RZ |
Action | Mechanism of Action | Reference |
---|---|---|
AGONIST | Insulin receptor agonist | DailyMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Myocardial Infarction | 3 | D009203 | ClinicalTrials |
Prediabetic State | 3 | D011236 | ClinicalTrials |
Hyperglycemia | 3 | D006943 | ClinicalTrials |
Cystic Fibrosis | 3 | D003550 | ClinicalTrials |
Hypertension | 3 | D006973 | ClinicalTrials |
Atherosclerosis | 3 | D050197 | ClinicalTrials |
Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
Coronary Disease | 3 | D003327 | ClinicalTrials |
Leukemia | 3 | D007938 | ClinicalTrials |
Lymphoma | 3 | D008223 | ClinicalTrials |
Diabetic Retinopathy | 0 | D003930 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 160337-95-1 |
ChEMBL | CHEMBL1201497 |
FDA SRS | 2ZM8CX04RZ |
Guide to Pharmacology | 7572 |
PubChem | 118984454 |